FI79105B - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,4-dihydropyridinfoereningar. - Google Patents
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,4-dihydropyridinfoereningar. Download PDFInfo
- Publication number
- FI79105B FI79105B FI842911A FI842911A FI79105B FI 79105 B FI79105 B FI 79105B FI 842911 A FI842911 A FI 842911A FI 842911 A FI842911 A FI 842911A FI 79105 B FI79105 B FI 79105B
- Authority
- FI
- Finland
- Prior art keywords
- sub
- pyrimidone
- process according
- methyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Polyesters Or Polycarbonates (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Registering, Tensioning, Guiding Webs, And Rollers Therefor (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Claims (8)
1. Förfarande för framställning av nya terapeutiskt användbara 1,4-dihydropyridinföreningar med formeln I och 5 farmaceutiskt godtagbara salter därav, a .r R1OOC^-><\^ COOR2 I I a)
10 H3C n /^'CH2-0-Y-X H i vilken formel R är 2-klorfenyl, 2,3-diklorfenyl eller 2-klor-3-trifluormetylfenyl, R1 och R2 betecknar oberoende 15 av varandra C2_4-alkyl eller 2-inetoxietyl, X är en 4-pyri-mldongrupp, som kan vara substituerad med en eller flera C14-alkyl-, fenyl- eller N(R3)2-grupper, där grupperna R3 är oberoende av varandra H eller -alkyl, eller bäda grupperna R3 bildar tillsammans med kväveatomen, tili vil-20 ken de är bundna med en piperidino- eller morfolinogrupp, Y är - (CH2 ) n -, -CH2CH(CH3)- eller -CH2 C( CH3 )2 -, och n är 1-3, dä X är bunden tili gruppen via en ringkolatom, eller 2 eller 3, dä X är bunden tili gruppen Y via en ring-kväveatom, kännetecknat därav, att en dihydro-25 pyridinketoester med formeln h\/r COnR2 I I (VI)
30. N CH2-0-Y-C0CH2C02R4
3 H väri R, R1 , R2 och Y betecknar samma som ovan och R4 är Ct _4-alkyl, omsätts med en förening med formeln 35 NH R5 -C . (Via) ^^NH2
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838319886A GB8319886D0 (en) | 1983-07-23 | 1983-07-23 | Therapeutic agents |
| GB8319886 | 1983-07-23 | ||
| GB8400354 | 1984-01-07 | ||
| GB848400354A GB8400354D0 (en) | 1984-01-07 | 1984-01-07 | Therapeutic agents |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI842911A0 FI842911A0 (fi) | 1984-07-19 |
| FI842911A FI842911A (fi) | 1985-01-24 |
| FI79105B true FI79105B (fi) | 1989-07-31 |
| FI79105C FI79105C (sv) | 1989-11-10 |
Family
ID=26286678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI842911A FI79105C (sv) | 1983-07-23 | 1984-07-19 | Förfarande för framställning av nya terapeutiskt användbara 1,4-dihydr opyridinföreningar. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4568677A (sv) |
| EP (1) | EP0132375B1 (sv) |
| AT (1) | ATE44146T1 (sv) |
| AU (1) | AU547188B2 (sv) |
| CA (1) | CA1265796A (sv) |
| CS (1) | CS241549B2 (sv) |
| DD (1) | DD226285A5 (sv) |
| DE (1) | DE3478746D1 (sv) |
| DK (1) | DK170069B1 (sv) |
| ES (1) | ES8700856A1 (sv) |
| FI (1) | FI79105C (sv) |
| GR (1) | GR82230B (sv) |
| HU (1) | HU212133B (sv) |
| IE (1) | IE58443B1 (sv) |
| IL (1) | IL72475A (sv) |
| NO (1) | NO161174C (sv) |
| NZ (1) | NZ208954A (sv) |
| PH (1) | PH20479A (sv) |
| PL (1) | PL142659B1 (sv) |
| PT (1) | PT78958B (sv) |
| YU (1) | YU43738B (sv) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8306666D0 (en) * | 1983-03-10 | 1983-04-13 | Pfizer Ltd | Therapeutic agents |
| GR851819B (sv) * | 1984-08-17 | 1985-11-26 | Wyeth John & Brother Ltd | |
| GB8501395D0 (en) * | 1985-01-19 | 1985-02-20 | Pfizer Ltd | Dihydropyridine anti-ischaemic & anti-hypertensive agents |
| US4833150A (en) * | 1985-03-14 | 1989-05-23 | Nelson Research & Development Co. | 1,4-dihydropyridines |
| JPS61227567A (ja) * | 1985-04-01 | 1986-10-09 | Eisai Co Ltd | １，４−ジヒドロピリジン誘導体 |
| WO1987000836A1 (en) * | 1985-08-06 | 1987-02-12 | Boehringer Biochemia Robin S.P.A. | Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines |
| IT1201454B (it) * | 1985-08-19 | 1989-02-02 | Boehringer Biochemia Srl | 1,4-diidropiridine-2-sostituite |
| GB8526411D0 (en) * | 1985-10-25 | 1985-11-27 | Pfizer Ltd | Dihydropyridines |
| GB8527698D0 (en) * | 1985-11-09 | 1985-12-11 | Pfizer Ltd | Dihydropyridine antiischaemic & antihypertensive agents |
| EP0225175A3 (en) * | 1985-11-28 | 1988-12-28 | FISONS plc | Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof |
| US4654372A (en) * | 1986-01-10 | 1987-03-31 | Warner-Lambert Company | Method for using verapamil for treating stroke |
| US4849436A (en) * | 1986-03-11 | 1989-07-18 | Nelson Research & Development Co. | 1,4-dihydropyridines |
| IT1197012B (it) * | 1986-07-29 | 1988-11-25 | Boehringer Biochemia Srl | 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono |
| GB8710493D0 (en) * | 1987-05-02 | 1987-06-03 | Pfizer Ltd | Dihydropyridines |
| US20070066619A1 (en) * | 2002-10-07 | 2007-03-22 | Artesian Therapeutics, Inc. | Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| EP1554267A1 (en) * | 2002-10-07 | 2005-07-20 | Artesian Therapeutics, Inc. | Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| CA2586870A1 (en) * | 2004-11-10 | 2006-05-18 | Synta Pharmaceuticals Corp. | Il-12 modulatory compounds |
| CN115557883A (zh) * | 2022-10-28 | 2023-01-03 | 常州制药厂有限公司 | 一种氨氯地平的合成工艺 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3363743D1 (en) * | 1982-07-22 | 1986-07-03 | Pfizer Ltd | Dihydropyridine anti-ischaemic and antihypertensive agents |
| PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
| EP0107293A3 (en) * | 1982-09-04 | 1984-06-06 | Pfizer Limited | Dihydropyridines |
| GB8414518D0 (en) * | 1984-06-07 | 1984-07-11 | Pfizer Ltd | Therapeutic agents |
-
1984
- 1984-06-21 US US06/623,265 patent/US4568677A/en not_active Expired - Lifetime
- 1984-07-18 DE DE8484304888T patent/DE3478746D1/de not_active Expired
- 1984-07-18 EP EP84304888A patent/EP0132375B1/en not_active Expired
- 1984-07-18 AT AT84304888T patent/ATE44146T1/de not_active IP Right Cessation
- 1984-07-19 CS CS845570A patent/CS241549B2/cs unknown
- 1984-07-19 FI FI842911A patent/FI79105C/sv not_active IP Right Cessation
- 1984-07-20 PT PT78958A patent/PT78958B/pt unknown
- 1984-07-20 DD DD84265515A patent/DD226285A5/de not_active IP Right Cessation
- 1984-07-20 ES ES534505A patent/ES8700856A1/es not_active Expired
- 1984-07-20 HU HU842823A patent/HU212133B/hu not_active IP Right Cessation
- 1984-07-20 DK DK355784A patent/DK170069B1/da not_active IP Right Cessation
- 1984-07-20 NZ NZ208954A patent/NZ208954A/xx unknown
- 1984-07-20 NO NO842987A patent/NO161174C/no not_active IP Right Cessation
- 1984-07-20 AU AU30899/84A patent/AU547188B2/en not_active Ceased
- 1984-07-20 PL PL1984248857A patent/PL142659B1/pl unknown
- 1984-07-20 CA CA000459336A patent/CA1265796A/en not_active Expired - Fee Related
- 1984-07-20 IL IL72475A patent/IL72475A/xx not_active IP Right Cessation
- 1984-07-20 GR GR75382A patent/GR82230B/el unknown
- 1984-07-20 PH PH31017A patent/PH20479A/en unknown
- 1984-07-23 YU YU1305/84A patent/YU43738B/xx unknown
- 1984-07-23 IE IE190584A patent/IE58443B1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI79105B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,4-dihydropyridinfoereningar. | |
| CS247073B2 (en) | Production method of 2-substituted 4-amino-6,7-dimethoxyghinolins | |
| JPS63258880A (ja) | 新規ピラゾロ〔３，４‐ｄ〕ピリミジン、その製法並びにアレルギー性疾患、及び炎症により誘発される気管支痙攣性及び気管支収縮性反応を治療する医薬 | |
| KR920005742B1 (ko) | 약제학상 유용한 디하이드로피리디닐디카르복실레이트 아마이드 및 에스테르의 제조방법 | |
| EP0106462B1 (en) | Dihydropyridines | |
| PL140573B1 (en) | Method of obtaining new dihydropyridine derivatives | |
| JPS6339875A (ja) | ピリミジン誘導体 | |
| US4618609A (en) | Anti-ischaemic and antihypertensive 2-[pyrimidyloxy alhoxymethyl]-1,4-dihydropyridines | |
| US6103724A (en) | 2-methoxyphenylpiperazine derivatives | |
| JPH05194441A (ja) | 新規な置換３−ピペラジニルアルキル−２，３−ジヒドロ−４ｈ−１，３−ベンゾオキサジン−４−オン、その製造法および治療用途 | |
| US5444056A (en) | Aminoalkoxyphenyl derivatives, process for their preparation and compositions containing them | |
| US4551534A (en) | Aralkyl or aryloxyalkyl 1,7-naphthyridine-3-carboxylic acid esters | |
| JPS63208580A (ja) | Ｎ置換３，４−ジヒドロピリミジン誘導体および循環器系疾患治療剤 | |
| US4596805A (en) | Substituted dioxopyridopyrimidines | |
| JPH0379359B2 (sv) | ||
| US4547502A (en) | Dihydropyridines and their use in treating cardiac conditions and hypertension | |
| KR20000032633A (ko) | 신규의 피리미딘 유도체 및 그의 제조방법 | |
| JP3269658B2 (ja) | フェノール誘導体 | |
| JPS641475B2 (sv) | ||
| US5441948A (en) | 1,3,4-benzotraizepin-5(4H)-one derivatives and process for the preparation thereof | |
| US4849429A (en) | Certain 1,4-dihydro-2,6-dilower-alkyl-4-(mono-substituted pyridyl) useful for treating coronary artery or cerebral artery disease | |
| JPH0676384B2 (ja) | １−クロル−５−イソキノリンスルホン酸 | |
| EP0165032A2 (en) | Dihydropyridine anti-ischaemic and antihypertensive agents | |
| US4593100A (en) | 3A,4,7,7a-tetrahydro-3,6,7a-trimethyl-4-substituted phenyl-isoxazolo[5,4-b]pyridine-5-carboxylic acid esters | |
| US4022905A (en) | Benzylidene hydrazino-1,2,4-triazoles, pharmaceuticals therewith, and method of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: PFIZER CORPORATION |